These authors detected down-regulation of pyruvate kinase M2 (PK-M2) in oxaliplatin-resistant cells and further demonstrated an inverse relationship between PK-M2 expression and oxaliplatin resistance in patients with colorectal cancer. The gene discussed is PKM; the disease is colorectal cancer.